The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Crutchfield Bradford since 2007.
This trader's CIK number is 1246406.
At the time of last reporting, Crutchfield Bradford was the Chief Commercial Officer of 10x Genomics, Inc.. (stock ticker symbol TXG).
Also see all insider trading activities at 10x Genomics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | BIO, BIOB | 0 | $0 | 0 | $0 | 240 | $0 |
2013 | BIO, BIOB | 0 | $0 | 0 | $0 | 4,960 | $215,000 |
2012 | BIO, BIOB | 0 | $0 | 4,268 | $438,944 | 4,720 | $142,000 |
2011 | BIO, BIOB | 0 | $0 | 8,087 | $854,261 | 8,480 | $256,440 |
2010 | BIO, BIOB | 0 | $0 | 0 | $0 | 240 | $0 |
2009 | BIO, BIOB | 0 | $0 | 2,086 | $204,716 | 2,000 | $71,000 |
2007 | BIO, BIOB | 0 | $0 | 8,200 | $609,260 | 8,200 | $88,150 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | TXG | 158 | $6,396 | 34,574 | $3,719,785 | 34,000 | $39,440 |
2021 | TXG | 0 | $0 | 204,832 | $33,691,293 | 258,598 | $406,985 |
2020 | TXG | 0 | $0 | 170,000 | $16,980,579 | 203,645 | $302,170 |
1. Bio-rad Laboratories, Inc. (BIO, BIOB)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-06-10 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2013-11-15 | BIO, BIOB | Option Ex | 4,000 | 53.75 | 215,000 |
2013-11-04 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2013-09-12 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2013-09-08 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2013-06-10 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2012-11-04 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2012-09-08 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2012-09-10 | BIO, BIOB | Sale | 92 | 103.49 | 9,521 |
2012-08-20 | BIO, BIOB | Option Ex | 4,000 | 35.50 | 142,000 |
2012-08-20 | BIO, BIOB | Sale | 4,000 | 103.11 | 412,440 |
2012-06-12 | BIO, BIO.B | Sale | 87 | 96.51 | 8,396 |
2012-06-11 | BIO, BIOB | Sale | 89 | 96.49 | 8,587 |
2012-06-10 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2011-11-16 | BIO, BIOB | Option Ex | 4,000 | 28.61 | 114,440 |
2011-11-16 | BIO, BIOB | Sale | 4,000 | 97.93 | 391,736 |
2011-09-08 | BIO, BIOB | Option Ex | 240 | .00 | 0 |
2011-06-14 | BIO, BIO.B | Sale | 87 | 117.53 | 10,225 |
2011-06-10 | BIO, BIO.B | Option Ex | 240 | .00 | 0 |
2011-03-02 | BIO, BIO.B | Option Ex | 4,000 | 35.50 | 142,000 |
2011-03-02 | BIO, BIO.B | Sale | 4,000 | 113.08 | 452,300 |
2010-06-10 | BIO, BIO.B | Option Ex | 240 | .00 | 0 |
2009-11-12 | BIO, BIO.B | Option Ex | 2,000 | 35.50 | 71,000 |
2009-11-12 | BIO, BIO.B | Sale | 2,000 | 99.09 | 198,180 |
2009-08-04 | BIO, BIO.B | Sale | 86 | 76.01 | 6,536 |
2007-06-04 | BIO | Option Ex | 8,200 | 10.75 | 88,150 |
2007-06-04 | BIO | Sale | 8,200 | 74.30 | 609,260 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-05-23 | TXG | Sale | 286 | 48.76 | 13,946 |
2022-05-13 | TXG | Buy | 158 | 40.49 | 6,396 |
2022-02-22 | TXG | Sale | 288 | 78.60 | 22,636 |
2022-02-15 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2022-02-15 | TXG | Sale | 17,000 | 95.13 | 1,617,261 |
2022-01-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2022-01-12 | TXG | Sale | 17,000 | 121.53 | 2,065,942 |
2021-12-21 | TXG | Option Ex | 54,598 | 3.12 | 170,345 |
2021-12-13 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-12-13 | TXG | Sale | 17,000 | 139.99 | 2,379,762 |
2021-11-22 | TXG | Sale | 281 | 148.38 | 41,695 |
2021-11-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-11-12 | TXG | Sale | 17,000 | 165.61 | 2,815,336 |
2021-10-12 | TXG | Sale | 17,000 | 157.51 | 2,677,636 |
2021-10-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-09-13 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-09-13 | TXG | Sale | 17,000 | 175.70 | 2,986,832 |
2021-08-23 | TXG | Sale | 270 | 161.85 | 43,698 |
2021-08-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-08-12 | TXG | Sale | 17,000 | 159.59 | 2,712,962 |
2021-07-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-07-12 | TXG | Sale | 17,000 | 188.34 | 3,201,797 |
2021-06-14 | TXG | Sale | 17,000 | 191.49 | 3,255,279 |
2021-06-14 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-05-24 | TXG | Sale | 281 | 162.66 | 45,707 |
2021-05-12 | TXG | Sale | 17,000 | 135.74 | 2,307,495 |
2021-05-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-04-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-04-12 | TXG | Sale | 17,000 | 186.25 | 3,166,250 |
2021-03-12 | TXG | Sale | 17,000 | 157.11 | 2,670,836 |
2021-03-12 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-02-01 | TXG | Sale | 17,000 | 176.48 | 3,000,194 |
2021-02-01 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-01-04 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2021-01-04 | TXG | Sale | 17,000 | 140.34 | 2,385,814 |
2020-12-28 | TXG | Option Ex | 33,645 | 3.12 | 104,972 |
2020-12-01 | TXG | Sale | 17,000 | 151.82 | 2,580,940 |
2020-12-01 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-11-02 | TXG | Option Ex | 10,504 | 1.16 | 12,184 |
2020-11-03 | TXG | Option Ex | 6,496 | 1.16 | 7,535 |
2020-11-02 | TXG | Sale | 10,504 | 137.19 | 1,441,085 |
2020-11-03 | TXG | Sale | 6,496 | 137.00 | 889,971 |
2020-10-01 | TXG | Sale | 17,000 | 125.65 | 2,136,067 |
2020-10-01 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-09-02 | TXG | Option Ex | 3,224 | 1.16 | 3,739 |
2020-09-01 | TXG | Sale | 13,776 | 114.20 | 1,573,205 |
2020-09-02 | TXG | Sale | 3,224 | 113.16 | 364,840 |
2020-09-01 | TXG | Option Ex | 13,776 | 1.16 | 15,980 |
2020-08-03 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-08-03 | TXG | Sale | 17,000 | 99.71 | 1,695,104 |
2020-07-01 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-07-01 | TXG | Sale | 17,000 | 87.93 | 1,494,810 |
2020-06-01 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-06-01 | TXG | Sale | 17,000 | 79.62 | 1,353,574 |
2020-05-01 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-05-01 | TXG | Sale | 17,000 | 78.02 | 1,326,374 |
2020-04-01 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-04-01 | TXG | Sale | 17,000 | 58.57 | 995,622 |
2020-03-06 | TXG | Option Ex | 17,000 | 1.16 | 19,720 |
2020-03-06 | TXG | Sale | 17,000 | 66.41 | 1,128,987 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Crutchfield Bradford (Chief Commercial Officer of 10x Genomics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.